Large-scale reference data sets of human genetic variation are critical for the medical and
functional interpretation of DNA sequence changes. Here we describe the aggregation and …

Genetic variants that inactivate protein-coding genes are a powerful source of information
about the phenotypic consequences of gene disruption: genes that are crucial for the function …

Genetic variants that inactivate protein-coding genes are a powerful source of information
about the phenotypic consequences of gene disruption: genes critical for an organism’s …

Congenital heart disease (CHD) patients have an increased prevalence of extracardiac
congenital anomalies (CAs) and risk of neurodevelopmental disabilities (NDDs). Exome …

Purpose: The accurate interpretation of variation in Mendelian disease genes has lagged
behind data generation as sequencing has become increasingly accessible. Ongoing large …

• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient’s interest, …

Background: A better understanding of the factors that contribute to heterogeneous outcomes
and lifetime disease burden in hypertrophic cardiomyopathy (HCM) is critically needed to …

Background Patients with dilated cardiomyopathy whose symptoms and cardiac function have
recovered often ask whether their medications can be stopped. The safety of withdrawing …

The recent discovery of heterozygous human mutations that truncate full-length titin (TTN, an
abundant structural, sensory, and signaling filament in muscle) as a common cause of end-…

Background Peripartum cardiomyopathy shares some clinical features with idiopathic dilated
cardiomyopathy, a disorder caused by mutations in more than 40 genes, including TTN, …